CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms by D&apos et al.
1Scientific RepoRts |          (2019) 9:2176  | https://doi.org/10.1038/s41598-018-38459-6
www.nature.com/scientificreports
CT Enhancement and 3D 
texture Analysis of pancreatic 
Neuroendocrine Neoplasms
Mirko D’Onofrio1, Valentina Ciaravino1, Nicolò Cardobi2, Riccardo De Robertis2, 
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to evaluate pancreatic neuroendocrine neoplasms (panNeNs) grade prediction by means of qualitative 
and quantitative CT evaluation, and 3D CT-texture analysis. Patients with histopathologically-
proven panNEN, availability of Ki67% values and pre-treatment CT were included. CT images were 
retrospectively reviewed, and qualitative and quantitative images analysis were done; for quantitative 
analysis four enhancement-ratios and three permeability-ratios were created. 3D CT-texture imaging 
analysis was done (Mean Value; Variance; Skewness; Kurtosis; Entropy). Subsequently, these 
features were compared among the three grading (G) groups. 304 patients affected by panNENs 
were considered, and 100 patients were included. At qualitative evaluation, frequency of irregular 
margins was significantly different between tumor G groups. At quantitative evaluation, for all ratios, 
comparisons resulted statistical significant different between G1 and G3 groups and between G2 and 
G3 groups. At 3D CT-texture analysis, Kurtosis resulted statistical significant different among three G 
groups and Entropy resulted statistical significant different between G1 and G3 and between G2 and G3 
groups. Quantitative CT evaluation of panNENs can predict tumor grade, discerning G1 from G3 and G2 
from G3 tumors. CT-texture analysis can predict panNENs tumor grade, distinguishing G1 from G3 and 
G2 from G3, and G1 from G2 tumors.
Tumor grade is the most important prognostic factor in pancreatic neuroendocrine neoplasms (PanNENs)1–3. 
According to the 2010 World Health Organization (WHO) classification4, PanNENs are classified into three groups 
based on their proliferative activity, expressed as mitotic count or Ki67 index: grade 1 (<2 mitoses/2 mm2/and/or 
Ki67 index ≤2%); grade 2 (2–20 mitoses/2 mm2 and/or a Ki67 index between 3 and 20%) and grade 3 (≥21 mitoses/2 
mm2 and Ki67 index >20%). According to European Neuroendocrine Tumor Society (ENETS) recommendations1, 
the assessment of tumor grade is essential for prediction of prognosis and choice of the proper treatment strategy.
The assessment of tumor grade can be achieved in an invasive way with biopsy or after surgery with surgical 
specimen histopathological analysis. Several studies attempted to identify radiological predictors of malignancy 
for PanNENs5–11, including tumor conspicuity in MDCT images, CT perfusion parameters, and values on MRI, 
including values in ADC and DWI images. Recently, computed analysis of imaging data has gained increasing 
interest due to the potential of predicting the aggressiveness of PanNENs12. Despite very few literature data, the 
computed texture analysis of computed tomography (CT) data seems to be able to provide predictive metrics for 
several pathological features. For example, Lubner MG et al.13 reported an association between CT texture fea-
tures with pathological features and clinical outcomes in patients with metastatic colorectal cancer.
The aim of this study was to evaluate PanNENs grade prediction possibility by means of CT qualitative and 
quantitative analysis as well as of CT 3D texture analysis.
Materials and Methods
Patients population and inclusion criteria. All procedures performed in studies involving human par-
ticipants were in accordance with the ethical standards of the institutional and/or national research committee 
and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
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Informed consent was obtained from each individual included in the study. This retrospective study was 
approved by institutional review board of the University of Verona.
A review of our radiological, surgical and histopathological databases for the period between January 2009 
and September 2016 identified all patients with PanNENs. The review board of GB Rossi University Hospital and 
Ospedale Pederzoli approve to merge and review the data.
Patients were included if fulfilled the following criteria: (a) histopathologically-proven PanNEN; (b) availabil-
ity of Ki67% values; (c) availability of a pre-treatment CT examination.
Exclusion criteria were: lack of pre-treatment CT examinations and/or absence of Ki67% values.
Image analysis. CT images were retrospectively reviewed by two radiologists in consensus expert in abdom-
inal radiology, blinded to histopathological features of PanNENs. Pre-contrast, pancreatic phase and portal phase 
images were retrieved from PACS and transferred to a personal computer for image analysis. Three different 
image analyses were conducted: qualitative analysis, quantitative analysis, and texture analysis.
Qualitative imaging analysis. Qualitative image analysis included: (a) margins of the lesion (sharp or 
irregular); (b) presence of intratumoral hypodense areas; (c) presence of calcifications; (d) dilation of the main 
pancreatic duct (MPD, >3 mm) and/or common bile duct (CBD, >1 cm); (e) involvement of peri-pancreatic ves-
sels; (f) presence of liver metastases; (g) tumor enhancement compared to pancreatic parenchyma (hyper-, iso-, 
or hypo-enhancing); (h) presence of inhomogeneous enhancement.
Quantitative imaging analysis. A ROI was drawn within the tumor on the CT slice in which the lesion 
showed its larger size (HUtumor), both in the arterial and in the portal phases. Care was taken during ROI position-
ing, in order to avoid adjacent vessels and calcifications. Circular ROIs were also placed in the adjacent pancreatic 
parenchyma (HUpancreas), within the aorta (HUaorta) and the portal vein (HUportal) for data comparison. ROIs were 
drawn on the CT image in which the tumor showed its greatest detectability and then automatically copied to the 
corresponding image on other CT phases. Owing to the variability between examinations and between patients, 
all values were considered as the ratio between tumor metrics and those of the adjacent parenchyma and the 
reference vessels.
The following values were considered: (a) relative enhancement ratio, expressed as tumor density compared 
to the adjacent parenchyma (HUtumor/HUpancreas) both in pancreatic (tumor parenchyma ratio 1) and in portal 
(tumor parenchyma ratio 2) phases; (b) standardized enhancement ratio, expressed both as the tumor density 
on the pancreatic phase compared with aortic enhancement (HUtumorART/HUaorta) (tumor arterial ratio) and the 
tumor density on the portal phase compared with portal enhancement (HUtumorPORT/HUportal) (tumor venous 
ratio); (c) tumor permeability ratio 1, defined as [(HUtumorART + HUtumorPORT)/HUaorta]; (d) tumor permeability 
ratio 2, defined as [(HUtumorPORT − HUtumorART)/HUaorta]; (e) tumor permeability ratio 3, defined as (HUtumorART/
HUtumorPORT)].
Texture imaging analysis. In order to standardize CT examinations, all images were digitally recon-
structed using a commercially available software (OsiriX Software, Pixmeo, Switzerland) with a slice thickness of 
5 mm. Imaging data were then analyzed by a dedicated software for CT texture analysis (MaZda v4.6, Technical 
University of Lodz, Institute of Electronics, Poland). ROIs were drawn on the CT pancreatic phase image or on 
the CT image in which the tumor showed the greatest detectability and then copied to the corresponding images 
on CT pancreatic phase. Three dimensional (3D) ROIs were obtained by a manual segmentation of the tumor 
boundaries (Fig. 1). The following parameters were obtained: (a) Mean Value; (b) Variance; (c) Skewness; (d) 
Kurtosis; (e) Entropy.
Statistical analysis. Tumors sizes were compared between tumor grades using Student’s T test. Categorical 
variables derived from the qualitative analysis were compared between tumor groups by using the χ2 test. 
Quantitative enhancement features and computed texture results were compared between groups using the 
Wilcoxon Mann-Whitman correlation test. Statistical analysis was conducted with commercially-available soft-
ware (Analyse-it Software, v4.5.1 and Med Calc, Microsoft partner, v17.2). P values < 0.05 were considered sta-
tistically significant. Receiver operating characteristic (ROC) curves were calculated for significant parameters.
Results
Patients population and tumors. From our Institute archives, 304 patients affected by PanNEN were 
considered. From these, 204 patients were excluded due to un-availability of CT examinations, caused by dam-
aged DICOM files or by old DICOM files not stored in the PACS. The 100 patients included were 55 males and 
45 females, had a mean age of 54.8 years (range: 18–86 years). Histopathological diagnosis was obtained in 37 
patients (37%) after surgical resection and with core-needle biopsy in 63 patients (63%). Tumor grade was G1 in 
31, G2 in 52 and G3 in 17 cases. The tumor was in the pancreatic head in 42 patients, in the pancreatic body-tail 
in 52, and 6 patients had a diffuse involvement of the pancreatic gland. In 4 patients with multiple tumors, the 
biggest lesion was chosen for evaluation.
The mean tumor size was 44 mm (range 10–132 mm) for G1 tumors; 51.81 mm (range 8–130 mm) for G2; 
52.35 mm (range 12–116 mm) for G3. No statistical significant differences were found for mean tumor size 
between groups (p > 0.05).
Qualitative imaging analysis. Qualitative analysis results are reported in Table 1. Tumor margins were 
sharp (Fig. 2a) in 74 patients (74%); this feature was more common among G1 tumors (97%) compared with G2 
and G3 tumors (69% and 47%, respectively). Tumor margins were irregular (Fig. 2b) in 26 patients (26%); this 
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feature was significantly more common among G3 tumors (53%) compared with G1 and G2 tumors (3% and 
31%, respectively). The frequency of irregular margins was significantly different between groups (p = 0.003). 
No significant differences between groups were found regarding the presence of hypodense areas, calcifications, 
upstream dilation of the MPD, CBD dilation, vascular involvement, liver metastases and enhancement.
Quantitative imaging analysis. Quantitative analysis results are reported in Table 2, where mean values, 
median and range of different enhancement ratio values and permeability ratios values are reported separately for 
G1, G2 and G3 groups respectively.
The mean HUtumor on pancreatic phase images was 107.46, whereas the mean HUtumor on portal phase images 
was 98.93. The mean HUtumor of G1 tumors was 121.90 HU [range 60–200 HU] on pancreatic phase images and 
103.83 [range 63–129] on portal phase images; the mean HUtumor of G2 panNENs was 107.86 [range 51–220] 
on the pancreatic phase and 98.84 [range, 46–143] on the portal phase; the mean HUtumor of G3 tumors was 
79.9462–129 on the pancreatic phase and 89.469–158 on the portal phase.
For all ratios, comparisons resulted significantly different between G1 and G3 groups (tumor parenchyma 
ratio 1 p < 0.0001; tumor parenchyma ratio 2 p = 0.0031; tumor arterial ratio p = 0.0007; tumor venous ratio 
p = 0.0003; tumor permeability ratio 1 p = 0.0123; tumor permeability ratio 2 p = 0.0026; tumor permeability ratio 
3 p = 0.0052), and between G2 and G3 groups (tumor parenchyma ratio 1 p = 0.0003; tumor parenchyma ratio 2 
p = 0.0388; tumor arterial ratio p = 0.0015; tumor venous ratio p = 0.0017; tumor permeability ratio 1 p = 0.0148; 
tumor permeability ratio 2 p = 0.0338; tumor permeability ratio 3 p = 0.0288), but not between G1 and G2 groups 
(tumor parenchyma ratio 1 p = 0.0762; tumor parenchyma ratio 2 p = 0.0247; tumor arterial ratio p = 0.1822; 
tumor venous ratio p = 0.1458; tumor permeability ratio 1 p = 0.3142; tumor permeability ratio 2 p = 0.1003; tumor 
permeability ratio 3 p = 0.1337).
Texture imaging analysis. Results of 3D CT texture analysis are reported in Tables 3 and 4. The mean 
texture values of G1 tumors were: Mean Value 202.01; Variance 5.07; Skewness −0.15; Kurtosis 0.07; Entropy 
0.02. The mean texture values of G2 tumors were: Mean Value 343.94; Variance 4.69; Skewness −0.11; Kurtosis 
0.44; Entropy 0.05. The mean texture values of G3 tumors were: Mean Value 186.63; Variance 5.5; Skewness 0.012; 
Kurtosis 1.88; Entropy 0.06.
Kurtosis was significantly different among the three G groups (p = 0.0063 in G1 vs G2; p = 0.0004 in G2 vs G3 
and p < 0.0001 in G1 vs G3) and Entropy differed significantly between G1 and G3 (p = 0.0013) and between G2 
and G3 (p = 0.0084) tumors.
Receiver operating characteristic (ROC) curve was calculated for kurtosis giving AUC value of 0.924 (Fig. 3) 
for the diagnosis of G3 with a sensitivity and a specificity of 82% and 85% respectively by using 0.8 cut-off value. 
ROC curve was calculated for Entropy giving AUC value of 0.732 (Fig. 4) for the diagnosis of G3 with a sensitivity 
and a specificity of 82% and 64% respectively by using 0.002 cut-off value.
Discussion
The aims of PanNENs imaging are detection, characterization and staging. To date, owing to technological devel-
opments, imaging could cover new significant roles, such as evaluation of tumor aggressiveness and prognostic 
prediction by assessing earlier therapeutic response14. Texture analysis that evaluates pixels values, variations 
and distribution using comparable parameters, has shown promising results in predicting tumor pathological 
features13,15–21, overall survival13,21–23, relapse risk24,25, and response to therapy26,27 for different tumors in differ-
ent organs. To date, there is no study on the role of texture analysis for pancreatic neuroendocrine neoplasms in 
Literature. In this study a CT qualitative, quantitative and texture analysis of PanNENs was performed.
At qualitative analysis, only tumor margins resulted to be a useful parameter. Qualitative analysis also showed 
differences in the most frequent presentation according to tumor grades. G1 tumors had more frequently sharp 
margins, no hypodense areas and no calcifications within the lesion, no dilation of main pancreatic duct and 
Figure 1. 3D ROI within a small neuroendocrine isthmus pancreatic tumor on CT image on pancreatic phase 
for texture analysis.
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Sharp 
margin 
n Pts 
/100 
(%)
Irregular 
margins 
n Pts /100 
(%)
Hypodense 
areas n Pts 
/100 (%)
Calcifications 
n Pts /100 (%)
Dilation 
MPD n Pts 
/100 (%) CBD 
n Pts 
/100 
(%)
Mets 
n Pts 
/100 
(%)
Vessels 
involvement 
n Pts /100 
(%)
Pancreatic phase n 
Pts /100 (%)
Portal phase n Pts 
/100 (%) Homo Enh 
n Pts 
/100 
(%)
Hetero 
Enh n 
Pts /100 
(%)
Mean 
caliber 
mm Hypo Iso Hyper Hypo Iso Hyper
G1 30 1 7 5
6
6 12 8 6 2 23 6 10 15 19 12
6.2
G2 36 16 16 18
11
5 32 35 23 2 27 16 9 27 19 33
9.1
G3 8 9 7 1
10
4 12 12 10 3 4 8 3 6 4 13
13.1
Tot 74 26 30 24 25 15 56 55 39 7 54 30 22 48 42 58
Table 1. Qualitative imaging analysis results, reported separately for G1, G2 and G3 respectively. n: number; 
Pts: Patients; MPD: main pancreatic duct; CBD: common bile duct; Hypo: hypodense; Iso: isodense; Hyper: 
hyperdense; Tot: total of patients; Mets: metastases; Homo Enh: homogeneous enhancement; Hetero Enh: 
heterogeneous enhancement.
Figure 2. (a,b) neuroendocrine pancreatic tumor with sharp (a) or irregular (b) margins at CT.
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common bile duct, no liver metastases, no involvement and/or infiltration of peri-pancreatic vessels, homogene-
ous enhancement, hyperdensity in both pancreatic and portal phases. G2 tumors most frequently presented with 
sharp margins, no hypodense areas and no calcifications within the lesion, no dilation of main pancreatic duct 
and common bile duct, they could have liver metastases, involvement and/or infiltration of peri-pancreatic ves-
sels, heterogeneous enhancement, and they were hyperdense in both pancreatic and portal phases. G3 tumors had 
most frequently irregular margins, no hypodense areas and no calcifications within the lesion, dilation of main 
pancreatic duct but not of common bile duct, liver metastases, involvement and/or infiltration of peri-pancreatic 
vessels, heterogeneous enhancement, and hypodense in both pancreatic and portal phases.
The quantitative analysis with enhancement ratios and permeability indexes permitted to distinguish G1 from 
G3 tumors and G2 from G3 tumors, while it did not permit to differentiate G1 from G2 tumors. These results 
are in general agreement with those present in Literature. Several studies showed correlations between imaging 
features of PanNENs, especially the type of enhancement, and histological findings5–11. With respect to other 
tumors, such as lung or breast cancers where a rich angiogenesis can be a predictive value of poor outcome28, 
the correlation between vascularization amount and aggressiveness in PanNENs is different. Overtly malignant 
and high-grade tumors have an altered vascularization, resulting in an atypical contrast enhanced pattern, such 
as hypovascularity in arterial phase or late enhancement in venous phase29. Belousova et al.5 concluded in their 
study that tumor size >2 cm, arterial enhancement ratio <1.1 (tumor to pancreas CE value in arterial phase), 
Tumor 
parenchyma 
ratio 1
Tumor 
arterial ratio
Tumor 
parenchyma 
ratio 2
Tumor venous 
ratio
Tumor 
permeability 
ratio 1
Tumor 
permeability 
ratio 2
Tumor 
permeability 
ratio 3
G1
Minimum 0.540540541 0.170542636 0.702479339 0.4375 0.390180879 −0.417112299 0.634615385
Maximum 3.23529411 0.909090909 3.323529412 0.975206612 1.401069519 0.114803625 1.847826087
Mean 1.280183312 0.4434636 1.231802514 0.69781458 0.820234284 −0.074654369 1.187411125
Median 1.171428571 0.4354 1.129374049 0.6966 0.8215 −0.05484 1.1441
G2
Minimum 0.520408163 0.169336384 0.429906542 0.298701299 0.389016018 −0.378600823 0.6375
Maximum 4 0.905349794 5.733333333 0.907801418 1.453947368 0.138157895 1.775280899
Mean 1.139382105 0.401851059 1.113379872 0.652510095 0.780080515 −0.033039593 1.082704628
Median 1.009747126 0.3733 1.058823529 0.6563 0.7655 0.002193 0.9944
G3
Minimum 0.532786885 0.168831169 0.642857143 0.4 0.409375 −0.12 0.677083333
Maximum 1.111111111 0.427083333 1.327731092 0.786069652 0.880434783 0.148867314 1.428571429
Mean 0.765634679 0.284325474 0.906113192 0.539758797 0.622256058 0.033944598 0.923392464
Median 0.736177885 0.2727 0.844320956 0.5132 0.6272 0.02273 0.8986
Table 2. Mean values and range of different enhancement ratio values and permeability indices in tumors 
divided according the tumor grade.
Mean Value Variance Skewness Kurtosis Entropy
G1
Minimum 65.344 1.103 −0.007679 −1.2813 0
Maximum 2117.600 33.718 0.35643 0.65087 0.3981
Mean 202.001581 5.07427097 −0.1521553 0.07386108 0.02500496
G2
Minimum 66.771 0.97089 −1.2643 −1.1067 0
Maximum 2119.600 15.147 0.77918 2.541 0.50326
Mean 343.942635 4.68824596 −0.1072736 0.4337585 0.04474871
G3
Minimum 67.087 1.0715 −0.81239 0.32116 0
Maximum 2054.7 22.598 1.1562 17.665 0.21121
Mean 186.629824 5.49595882 0.01199882 2.81655765 0.06323646
Table 3. Mean values and range of 3D CT texture analysis parameters in tumors divided according the tumor 
grade.
G1 vs G2 G2 vs G3 G1 vs G3
Mean Value p = 0.2123 p = 0.0842 p = 0.0113
Variance p = 0.8580 p = 0.1032 p = 0.1922
Skewness p = 0.4457 p = 0.3580 p = 0.2958
Kurtosis p = 0.0063 p < 0.0001 p < 0.0001
Entropy p = 0.2623 p = 0.0084 p = 0.0013
Table 4. Comparison among three-dimensional computed texture analysis parameters obtained in the three 
grading groups using the Mann-Whitney correlation test.
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and late contrast enhancement were indicative of G2 tumors, and this information could be used to support 
decisions considering the extent of tumor resection or the possibility of a conservative approach allowing for 
individualized decision making. Cappelli et al.6 reported that contrast enhancement pattern of PanNENs, as 
determined during multiphasic study, correlated with histological grading, allowing to predict their biological 
behavior. In their study, a lesion showing type A pattern of contrast enhancement (early CE in arterial phase and 
rapid wash-out resulting hypodense in portal phase) can be reasonably considered as benign; on the contrary 
type B2 (delayed CE in venous and late phases) should be considered strongly suggestive of malignancy. Kim et 
al.7 reported that G3 neuroendocrine carcinomas had characteristic CT features, such as portal enhancement 
ratio <1.1, poorly defined margin, tumor size >3 cm, bile duct dilation, and vascular invasion. Consequently, 
they concluded that when these CT findings are used in combination, G3 NECs can be differentiated from G1and 
Figure 3. Receiver operating characteristic (ROC) curve for kurtosis giving AUC value of 0.924 for the 
diagnosis of G3 with a sensitivity and a specificity of 82% and 85% respectively by using 0.8 cut-off value.
Figure 4. Receiver operating characteristic (ROC) curve for Entropy giving AUC value of 0.732 for the 
diagnosis of G3 with a sensitivity and a specificity of 82% and 64% respectively by using 0.002 cut-off value.
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G2 NETs with high diagnostic accuracy. Luo et al.9 showed that multi-slice computed tomography imaging is a 
feasible technique for predicting the pathological classification of PanNENs: peri-pancreatic tissue or vascular 
invasion and lesser enhancement at the arterial phase were significantly correlated with higher grade PanNENs. 
Takumi et al.10 found that a combination of CT features, including tumor size (≥20 mm), metastases and tumor 
conspicuity led to an increased diagnostic accuracy for G2 PanNENs, compared to each approach alone. They 
found that a larger tumor size (≥20 mm) and non-hyperattenuation during the portal/venous phase were associ-
ated with G2 PanNENs, suggesting that contrast-enhanced CT features may help predict the pathological tumor 
grades. Yamada et al.11 affirmed in their study that the degree of CT enhancement in the pancreatic phase was a 
significant predictor of G2 PanNENs.
In the present study, CT texture analysis discerned G1 from G2 and G3 tumors, and G2 form G3 tumors with 
a statistically significant difference. The most important CT texture analysis parameter resulted to be Kurtosis, 
but also Entropy values resulted significantly different in the distinction of G1 from G3 tumors and G2 from G3 
tumors. As a consequence, CT texture analysis has a superior performance in the prediction of PanNEN tumor 
grade, in comparison to qualitative and quantitative analysis.
This analysis proved to be useful in studying different tumors in other organs. Liu S et al.15 reported that 
CT texture analysis held great potential in predicting differentiation degree, Lauren classification and vascular 
invasion status of gastric cancers. Yasaka et al.16 showed that using CT quantitative texture analysis high-risk 
thymic epithelial tumor can be differentiated from low-risk ones with a high diagnostic performance. Liu Y et al.17 
revealed in their study that texture analysis on contrast enhanced CT images could be helpful in predicting patho-
logic grade of lung adenocarcinoma. Yu et al.18 concluded their study affirming that texture analysis is a promising 
non-invasive tool for distinguishing renal tumors on CT images. Hodgdon et al.19 affirmed that CT texture anal-
ysis can be used to accurately differentiate fat-poor angiomyolipoma from renal cell carcinoma on unenhanced 
CT images. Zhang et al.20 proved that CT texture analysis is a feasible tool for differentiating low-grade urothelial 
carcinoma from high-grade ones.
Our data suggest that CT texture analysis could have an oncologic application in the clinical practice reporting 
data not visible but present in the diagnostic CT images, as already stated in Literature14. Choi et al.30 found inter-
esting results in distinguishing PanNENs G1 from G2/G3 by using CT texture analysis. In the paper the majority 
of the included tumors were G1 (n = 45) whereas there were few G3 tumors (n = 5). Moreover, for Kurtosis cal-
culation the CT portal phase were analyzed. Some differences in the results in respect to our study are therefore 
expected. Of the 100 PanNENs included in our study, 31 were G1, 52 were G2 and 17 were G3, and moreover no 
statistical significant difference in tumor dimensions were found in the study population. 3D texture analysis was 
performed in all cases by using CT arterial phase that represents the best dynamic phase able to potentially high-
light the tumor arterial network. Therefore, our results seem to come from a correct evaluation of a well distrib-
uted study population. In the present study statistical significant difference were found in the Entropy between 
G1 and G3 and G2 and G3 and in the Kurtosis between G1 and G2, G2 and G3, G1 and G3. In particular, in the 
present study G3 tumors showed higher values of Kurtosis and this is graphically represented by a leptokurtic 
distribution related to the more presence of intra-tumoral fibrosis/necrosis. On the opposite G1 tumors Kurtosis 
results are graphically represented by a platykurtic distribution related to the more homogeneous representation 
of all tissue components, in many cases as in the pancreatic parenchyma.
A possible clinical scenario can be supposed: in the same moment that a neuroendocrine neoplasm is 
detected, characterized and staged, texture analysis could provide tumor grade prediction, allowing better patient 
management.
Limitations of our study were the retrospective design of the study and the inclusion of core-needle biopsies 
together with resected specimens for the final pathological diagnosis and tumor grade evaluation. Prospective 
studies are expected in order to confirm present results, clarifying possible differences with previous or other 
studies in this field.
Conclusion
Quantitative CT evaluation of PanNENs can predict tumor grade, discerning G1 from G3 and G2 from G3 tum-
ors. CT texture analysis can predict PanNENs tumor grade, distinguishing G1 from G3, G2 from G3, and G1 from 
G2 tumors. CT texture analysis parameters therefore could be a useful surrogate for neuroendocrine pancreatic 
neoplasms grading.
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